Cefoperazone is a broad-spectrum, third-generation cephalosporin antibiotic used to treat severe bacterial infections. As a cephalosporin, it belongs to the class of beta-lactam antibiotics, which work by inhibiting bacterial cell wall synthesis. It is one of the few cephalosporin antibiotics effective against Pseudomonas bacterial infections that are typically resistant to this class of drugs. It was patented in 1974 and received approval for medical use in 1981.
BRAND NAMES
Combination product brand names:
Sulperazon: Marketed by Pfizer internationally.
Magnex: Another Pfizer brand name, used in regions like India.
Zostum: A brand manufactured by Zuventus, available in countries such as India.
Viatran: A brand from Cipla.
Lactagard: Marketed by Ipca Laboratories.
Single-drug brand names:
Cefobid: The original brand name for cefoperazone alone.
Cefazone: Another name for the single agent.
Kephazon: A brand from United Biotech.
Purecef: Marketed by Samarth Life Sciences.
MECHANISM OF ACTION
Cefoperazone, a third-generation cephalosporin antibiotic, works by inhibiting the final stage of bacterial cell wall synthesis. Like other beta-lactam antibiotics, it achieves this by binding to and inactivating penicillin-binding proteins (PBPs) inside the bacterial cell wall.
PHARMACOKINETICS
Absorption
Cefoperazone is not absorbed orally and must be administered by injection, either intravenously (IV) or intramuscularly (IM). An intravenous injection provides immediate, complete (100%) bioavailability, quickly achieving peak serum concentrations. After an intramuscular injection, the drug is well absorbed, with maximum serum concentrations typically reached within one to two hours.
Distribution
The apparent volume of distribution for cefoperazone ranges from 9.9 to 16 liters.
Metabolism
Cefoperazone is minimally metabolized and primarily eliminated through the bile into the feces. A smaller amount is excreted by the kidneys. Its half-life is significantly prolonged in severe liver disease or biliary obstruction. Metabolism of a side chain releases N-methylthiotetrazole, which can cause bleeding risk by interfering with vitamin K and a reaction with alcohol.
Excretion
Cefotetan is approximately 88% bound to plasma proteins, and no significant metabolites have been detected in the urine. Cefoperazone is primarily eliminated through the bile. Its average serum half-life is about 2.0 hours, regardless of the route of administration.
PHARMACODYNAMICS
Cefoperazone is a third-generation cephalosporin antibiotic that primarily works by disrupting the synthesis of the bacterial cell wall. It is a time-dependent bactericidal drug, meaning its effectiveness depends on the duration of its concentration above the minimum inhibitory concentration (MIC), rather than the peak concentration.
ADMINISTRATION
Cefoperazone is an injectable antibiotic administered either intravenously (IV) or intramuscularly (IM) by a qualified healthcare professional, typically in a hospital or clinic. It is most commonly available as a powder that must be reconstituted (dissolved) with a compatible solution before injection.
DOSAGE AND STRENGTHS
The following strengths are commonly available in vials for reconstitution:
Cefoperazone alone: 1 gram and 2 grams
Cefoperazone and sulbactam combination:
1 gram cefoperazone + 0.5 gram sulbactam
1 gram cefoperazone + 1 gram sulbactam
2 grams cefoperazone + 1 gram sulbactam
DRUG INTERACTIONS
Cefoperazone has significant drug interactions, particularly with anticoagulants like warfarin, where it can increase bleeding risk due to its NMTT side chain inhibiting clotting factors. Alcohol consumption during treatment and for up to 72 hours after the last dose should be strictly avoided, as it can cause a severe disulfiram-like reaction. Co-administration with other medications also requires caution, including with aminoglycosides due to increased risk of kidney and ear toxicity, and with probenecid which elevates cefoperazone's serum concentration. Patients with liver or kidney impairment, vitamin K deficiency, or poor nutrition are at a higher risk for complications, necessitating close monitoring and potential dosage adjustment.
FOOD INTERACTIONS
Food interactions with cefoperazone are primarily related to alcohol consumption and the potential for stomach upset. There are no specific dietary restrictions for most foods while taking this antibiotic.
CONTRAINDICATIONS
Cefoperazone is contraindicated in patients with a known allergy to penicillins, sulbactam, cefoperazone, or any cephalosporin antibiotics. Serious, and in some cases fatal, hypersensitivity (anaphylactic) reactions have been reported in individuals receiving beta-lactam or cephalosporin therapy.
SIDE EFFECTS
Common side effects:
Diarrhea.
Nausea and vomiting.
Injection site reactions.
Skin reactions.
Serious side effects:
Severe diarrhea.
Allergic reactions.
Blood disorders.
Liver and kidney issues.
Neurological effects.
OVERDOSE
Neurological symptoms:
Seizures
Neuromuscular hypersensitivity
Encephalopathy (altered brain function)
Confusion
Dizziness
Gastrointestinal symptoms:
Severe nausea and vomiting
Severe diarrhea
Abdominal pain
Hematological (blood-related) symptoms:
Hypoprothrombinemia (a blood-clotting disorder)
Bleeding.
TOXICITY
Cefoperazone toxicity is primarily associated with its N-methylthiotetrazole (NMTT) side chain, which can cause bleeding problems and a reaction to alcohol. The drug can also lead to allergic reactions, gastrointestinal issues, and, in rare cases, nervous system toxicity.